Richard Jay Smeyne (Richard J Smeyne, Richard Smeyne)

ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 10

Top Venues

NPJ Parkinson's disease

The Journal of neuroscience : the official journal of the Society for Neuroscience

Research square

Science (New York, N.Y.)

Thomas Jefferson University

Thomas Jefferson University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Thomas Jefferson University Jul 01 2016

United States

Director, Jefferson Comprehensive Parkinson's and Movement Disorder Center :: Neurosciences

Saint Jude Children's Research Hospital Jul 03 1996 - Jun 30 2016

United States

Member :: Developmental Neurobiology

Hoffmann-LaRoche May 02 1994 - Jun 30 1996

United States

Head of Program :: Neurogenetics

Bristol-Myers Squibb Pharmaceutical Research and Development Jun 23 1991 - May 01 1994

United States

PI :: Molecular Biology

Education History

Thomas Jefferson University Sep 01 1984 - Jun 22 1989

United States

PHD :: Anatomy

Publications

Lara Cheslow, Matthew Byrne, Jessica S Kopenhaver, Lorraine Iacovitti, Richard Jay Smeyne, Adam E Snook, Scott A Waldman
GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults. NPJ Parkinson's disease 10 (1) (2024)
Lara Cheslow, Matthew Byrne, Jessica S Kopenhaver, Lorraine Iacovitti, Richard Jay Smeyne, Adam E Snook, Scott A Waldman
GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults. NPJ Parkinson's disease 10 (1) (2024)
Lara Cheslow, Matthew Byrne, Jessica S Kopenhaver, Lorraine Iacovitti, Richard Jay Smeyne, Adam E Snook, Scott A Waldman
GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults. NPJ Parkinson's disease 10 (1) (2024)
Lara Cheslow, Matthew Byrne, Jessica S Kopenhaver, Lorraine Iacovitti, Richard Jay Smeyne, Adam E Snook, Scott A Waldman
GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults. NPJ Parkinson's disease 10 (1) (2024)
Lara Cheslow, Matthew Byrne, Jessica S Kopenhaver, Lorraine Iacovitti, Richard Jay Smeyne, Adam E Snook, Scott A Waldman
GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults. NPJ Parkinson's disease 10 (1) (2024)
Richard Jay Smeyne
In memorium, Michael Zigmond, PhD. NPJ Parkinson's disease 9 (1) (2023)
Scott Waldman, Lara Cheslow, Matthew Byrne, Jessica Kopenhaver, Lorraine Iacovitti, Richard Jay Smeyne, Adam E Snook
GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults. Research square (2023)
Richard Jay Smeyne, Jeffrey B Eells, Debotri Chatterjee, Matthew Byrne, Shaw M Akula, Srinivas Sriramula, Dorcas P O'Rourke, Peter Schmidt
COVID-19 Infection Enhances Susceptibility to Oxidative Stress-Induced Parkinsonism. Movement disorders : official journal of the Movement Disorder Society 37 (7) (2022)
Elena Kozina, Matthew Byrne, Richard Jay Smeyne
Mutant LRRK2 in lymphocytes regulates neurodegeneration via IL-6 in an inflammatory model of Parkinson's disease. NPJ Parkinson's disease 8 (1) (2022)
Jay A Blundon, Noah C Roy, Brett J W Teubner, Jing Yu, Tae-Yeon Eom, K Jake Sample, Amar Pani, Richard Jay Smeyne, Seung Baek Han, Ryan A Kerekes, Derek C Rose, Troy A Hackett, Pradeep K Vuppala, Burgess B Freeman, Stanislav S Zakharenko
Restoring auditory cortex plasticity in adult mice by restricting thalamic adenosine signaling. Science (New York, N.Y.) 356 (6345) (2018)
Sebastien Gingras, Laurie R Earls, Sherie Howell, Richard Jay Smeyne, Stanislav S Zakharenko, Stephane Pelletier
SCYL2 Protects CA3 Pyramidal Neurons from Excitotoxicity during Functional Maturation of the Mouse Hippocampus. The Journal of neuroscience : the official journal of the Society for Neuroscience 35 (29) (2015)

Richard Jay Smeyne.css-eqlu8i{font-size:small;padding-left:4px;} (Richard J Smeyne, Richard Smeyne)

Publication Activity (10 Years)

Top Topics

Top Venues

Richard Jay Smeyne (Richard J Smeyne, Richard Smeyne)